SHANGHAI, Feb. 23,
2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD)
("Zhongchao" or the "Company"), a platform-based internet
technology company offering services to patients with oncology and
other major diseases, today announced the renewal of the
partnership between Zhongchao Medical Technology (Shanghai) Co., Ltd. ("Zhongchao Shanghai"), of
which Zhongchao consolidates the operations and financial results
through a series of contractual arrangements and Johnson &
Johnson (China) Investment Limited
("J&J"). The renewed partnership is expected to further
strengthen two parities' cooperation in the global advanced field
of innovative medical and health.
As the first Fortune 500 company to position the Chinese market
as a "global innovation engine," J&J is committed to providing
innovative comprehensive medical solutions for Chinese patients and
medical and health professionals, the vision of which is also
shared with Zhongchao. Zhongchao Shanghai
and its subsidiaries are equipped with independent research
and development ability of innovative medical education solutions
such as Practical Improvement (PI),
Community of Practice Share (COPS), medical doctrines, AI knowledge
maps, and educational technology modules such as thinking
training. Zhongchao Shanghai has developed professional and
rich medical content production capabilities and stringent quality
control processes. Pursuant to the cooperation agreement, Zhongchao
Shanghai will provide digital education, multimedia courseware
production, medical editing, and related design services for
J&J in mainland China.
Weiguang Yang, Chairman and Chief
Executive Officer of Zhongchao, commented, "we are thrilled to
announce the extension of our cooperation with J&J since 2017,
following our last renewal in 2020. We remain committed to
deepening our cooperation with J&J in the field of serving
patients' health, with the aim of providing the best comprehensive
diagnostic and therapeutic solutions based on the benefits of
patients and consumers. The MDMOOC platform provides year-round
online professional medical training and education services for
medical workers to improve their diagnostic and therapeutic
capabilities, increase the accessibility and affordability of
medical and health services, and promote the popularization of
quality medical resources. Together with J&J, we intend to
combine our respective expertise and resources to address the
challenges in the healthcare market and deliver innovative medical
solutions to patients. Meanwhile, we look forward to continuing our
efforts to advance digital medical education in the healthcare
related markets."
About Zhongchao Inc.
Zhongchao Inc. is an offshore holding company incorporated in
the Cayman Islands. It conducts
operations in China through the
contractual arrangements between its wholly owned subsidiary and
PRC operating entities. Zhongchao Inc. is a platform-based internet
technology company offering services to patients with oncology and
other major diseases. The PRC operating entities provide online
healthcare information, professional training and educational
services to healthcare professionals under their "MDMOOC" platform
(www.mdmooc.org), offer patient management services in the
professional field of tumor and rare diseases through Zhongxin,
offer internet healthcare services through Zhixun Internet
Hospital, and pharmaceutical services through Xinjiang Medical and
operate an online information platform, Sunshine Health Forums, to
general public. More information about the Company can be found at
its investor relations website at http://izcmd.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's goals and strategies; the Company's
future business development; product and service demand and
acceptance; changes in technology; economic conditions; the growth
of the professional training and educational services market in
China and the other international
markets the Company plans to serve; reputation and brand; the
impact of competition and pricing; government regulations;
fluctuations in general economic and business conditions in
China and the international
markets the Company plans to serve and assumptions underlying or
related to any of the foregoing and other risks contained in
reports filed by the Company with the SEC, the length and severity
of the recent coronavirus outbreak, including its impacts across
our business and operations. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no
obligation to publicly revise these forward–looking statements to
reflect events or circumstances that arise after the date
hereof.
For more information, please contact:
At the Company: Pei Xu, CFO
Email: xupei@mdmooc.org
Phone: +86 13901629242
Investor Relations: Sherry Zheng
Weitian Group LLC
Email: shunyu.zheng@weitian-ir.com
Phone: +1 718-213-7386
View original
content:https://www.prnewswire.com/news-releases/zhongchao-inc-renews-partnership-with-johnson--johnson-china-301753984.html
SOURCE Zhongchao Inc.